Telling the story: art’s potential to boost trial diversity
Lifeology is harnessing the art of visual storytelling to help fight mistrust and misinformation in the age of the ‘infodemic.’
By
Companies
Latest in
Companies
Impressive early results for Vertex’s potentially curative stem cell diabetes therapy
A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its synthetic insulin…
By
Delivering gene therapy directly to the brain for AADC deficiency
PTC Therapeutics’ gene therapy delivered directly to the brain is yielding life-changing results in children with AADC deficiency.
By
Decentralised clinical trials: movers and shakers to watch
Amid Covid-19, the prevalence of decentralised trials has shot up. Here are six firms that stand out in this increasingly…
By
Moderna set to start human trials of experimental mRNA HIV vaccine
Moderna could start a Phase I trial of its mRNA HIV vaccine as early as this week, according to a…
By
Path clears for Novartis’s Zolgensma after FDA lifts longstanding hold
After allaying safety concerns, Novartis is set to start the Phase III STEER trial of Zolgensma in SMA patients aged…
By
myMedidata Registries: engaging patients pre-trial, throughout and beyond
Kelly McKee discusses myMedidata Registries, the new platform aiming to offer premium patient engagement in clinical trials.
By
Covaxin commences Covid-19 vaccine clinical trials in children
India’s indigenous Covid-19 vaccine starts trials in children amid concerns around how emerging strains may affect youth.
By